The first half of 2021 has seen more brand-name drug list price increases than all of 2020, according to an analysis by 46Brooklyn, a nonprofit drug research firm.
The increases reverse the downward trend in brand-name drug price increase frequency that's been observed over the last decade, 46Brooklyn reported.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,